398 related articles for article (PubMed ID: 25244263)
1. Experimental investigation of relationship between trauma and bisphosphonate-related osteonecrosis.
Agaçayak KS; Yuksel H; Atilgan S; Koparal M; Uçan MC; Ozgöz M; Yaman F; Atalay Y; Acikan I
Niger J Clin Pract; 2014; 17(5):559-64. PubMed ID: 25244263
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
[TBL] [Abstract][Full Text] [Related]
3. C-terminal cross-linking telopeptide as a serologic marker for bisphosphonate-related osteonecrosis of the jaw: review of 2 cases.
Pasoff M
J Can Dent Assoc; 2013; 79():d51. PubMed ID: 23920073
[TBL] [Abstract][Full Text] [Related]
4. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
[TBL] [Abstract][Full Text] [Related]
5. A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery?
O'Connell JE; Ikeagwani O; Kearns GJ
Ir J Med Sci; 2012 Jun; 181(2):237-42. PubMed ID: 22223192
[TBL] [Abstract][Full Text] [Related]
6. The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study.
Dayisoylu EH; Şenel FÇ; Üngör C; Tosun E; Çankaya M; Ersöz S; Taskesen F
Int J Oral Maxillofac Surg; 2013 Nov; 42(11):1475-80. PubMed ID: 23746422
[TBL] [Abstract][Full Text] [Related]
7. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study.
Lee CY; Suzuki JB
Implant Dent; 2010 Feb; 19(1):29-38. PubMed ID: 20147814
[TBL] [Abstract][Full Text] [Related]
8. Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers.
Fleisher KE; Welch G; Kottal S; Craig RG; Saxena D; Glickman RS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):509-16. PubMed ID: 20674404
[TBL] [Abstract][Full Text] [Related]
9. Dental extraction following zoledronate, induces osteonecrosis in rat's jaw.
Vidal-Gutiérrez X; Gómez-Clavel JF; Gaitán-Cepeda LA
Med Oral Patol Oral Cir Bucal; 2017 Mar; 22(2):e177-e184. PubMed ID: 28160593
[TBL] [Abstract][Full Text] [Related]
10. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Sonis ST; Watkins BA; Lyng GD; Lerman MA; Anderson KC
Oral Oncol; 2009 Feb; 45(2):164-72. PubMed ID: 18715819
[TBL] [Abstract][Full Text] [Related]
11. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
Kunchur R; Need A; Hughes T; Goss A
J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
[TBL] [Abstract][Full Text] [Related]
12. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
Marx RE; Cillo JE; Ulloa JJ
J Oral Maxillofac Surg; 2007 Dec; 65(12):2397-410. PubMed ID: 18022461
[TBL] [Abstract][Full Text] [Related]
13. Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates.
Bagan JV; Jiménez Y; Gómez D; Sirera R; Poveda R; Scully C
Oral Oncol; 2008 Nov; 44(11):1088-9. PubMed ID: 18396443
[TBL] [Abstract][Full Text] [Related]
14. Development of a rat model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Marino KL; Zakhary I; Abdelsayed RA; Carter JA; O'Neill JC; Khashaba RM; Elsalanty M; Stevens MR; Borke JL
J Oral Implantol; 2012 Sep; 38 Spec No():511-8. PubMed ID: 21905888
[TBL] [Abstract][Full Text] [Related]
15. CTX as a marker for BRONJ.
Bouchard C; Fortin M
J Can Dent Assoc; 2013; 79():d173. PubMed ID: 24309053
[No Abstract] [Full Text] [Related]
16. Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw.
Hewson I; Syme D; Bruscino-Raiola F
Aust Dent J; 2012 Jun; 57(2):227-30. PubMed ID: 22624766
[TBL] [Abstract][Full Text] [Related]
17. Bacterial promotion of bisphosphonate-induced osteonecrosis in Wistar rats.
Tsurushima H; Kokuryo S; Sakaguchi O; Tanaka J; Tominaga K
Int J Oral Maxillofac Surg; 2013 Nov; 42(11):1481-7. PubMed ID: 23932020
[TBL] [Abstract][Full Text] [Related]
18. Serum CTX to prevent osteonecrosis/orthodontic extraction of third molars: paths toward minimizing surgical risk?
Assael LA
J Oral Maxillofac Surg; 2007 Dec; 65(12):2395-6. PubMed ID: 18022460
[No Abstract] [Full Text] [Related]
19. Bisphosphonate-associated osteonecrosis of the jaw 2 years after teeth extractions: a case report solved with non-invasive treatment.
Gómez-Moreno G; Arribas-Fernández MC; Fernández-Guerrero M; Boquete-Castro A; Aguilar-Salvatierra A; Guardia J; Botticelli D; Calvo-Guirado JL
Eur Rev Med Pharmacol Sci; 2014; 18(9):1391-7. PubMed ID: 24867519
[TBL] [Abstract][Full Text] [Related]
20. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]